138 related articles for article (PubMed ID: 2671289)
41. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity].
Watanabe N; Kaneko T; Fujitani S; Umeyama M; Nomura Y; Zusho H; Yamada Y; Nanba G; Asahina N; Sugio Y; Okamoto Y; Daida T; Tokumaru T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):101-6. PubMed ID: 9987505
[TBL] [Abstract][Full Text] [Related]
42. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
43. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
Bonomi PD; Finkelstein DM; Ruckdeschel JC; Blum RH; Green MD; Mason B; Hahn R; Tormey DC; Harris J; Comis R
J Clin Oncol; 1989 Nov; 7(11):1602-13. PubMed ID: 2553879
[TBL] [Abstract][Full Text] [Related]
44. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340
[TBL] [Abstract][Full Text] [Related]
45. Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.
Dimery IW; Brooks BJ; Winn R; Martin T; Shirinian M; Hong WK
J Clin Oncol; 1991 Nov; 9(11):1939-44. PubMed ID: 1941052
[TBL] [Abstract][Full Text] [Related]
46. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].
Klima A; von Ilberg C; Bergmann L; Zoubek A; Klippstein T; Mitrou PS; Szepesi S
HNO; 1987 Feb; 35(2):78-83. PubMed ID: 2437086
[TBL] [Abstract][Full Text] [Related]
47. Combination chemotherapy with carboplatin and bleomycin for advanced and recurrent head and neck cancer: a phase II study.
Gonzalez-Vela JL; Panasci L; Black M; Pollak M; Margolese R
J Surg Oncol; 1988 Nov; 39(3):215-6. PubMed ID: 2460704
[TBL] [Abstract][Full Text] [Related]
48. Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinoma.
Edmonson JH; McCormack GW; Krook JE; Long HJ; Jefferies JA; Richardson RL
Cancer Treat Rep; 1987 Feb; 71(2):199-200. PubMed ID: 3542210
[TBL] [Abstract][Full Text] [Related]
49. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
[TBL] [Abstract][Full Text] [Related]
50. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.
Fennelly D; Wasserheit C; Schneider J; Hakes T; Reich L; Curtin J; Yao TJ; Markman M; Norton L; Crown J
Cancer Res; 1994 Dec; 54(23):6137-42. PubMed ID: 7525055
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer.
Pitman SW; Kowal CD; Bertino JR
Semin Oncol; 1983 Jun; 10(2 Suppl 2):15-9. PubMed ID: 6346497
[TBL] [Abstract][Full Text] [Related]
53. Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Adamo V; Maisano R; Pergolizzi S; Altavilla G; Caristi N; Chiofalo G; Scimone A; Settineri N
J Chemother; 1997 Feb; 9(1):72-6. PubMed ID: 9106022
[TBL] [Abstract][Full Text] [Related]
54. Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
Katakami N; Takada M; Negoro S; Ota K; Fujita J; Furuse K; Ariyoshi Y; Ikegami H; Fukuoka M
Cancer; 1996 Jan; 77(1):63-70. PubMed ID: 8630941
[TBL] [Abstract][Full Text] [Related]
55. [Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
Jakse R; Scherlacher A; Lehnert M; Haas J
HNO; 1986 Jun; 34(6):235-40. PubMed ID: 3744908
[TBL] [Abstract][Full Text] [Related]
56. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
Baselga J; Trigo JM; Bourhis J; Tortochaux J; Cortés-Funes H; Hitt R; Gascón P; Amellal N; Harstrick A; Eckardt A
J Clin Oncol; 2005 Aug; 23(24):5568-77. PubMed ID: 16009950
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
[TBL] [Abstract][Full Text] [Related]
58. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N
J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565
[TBL] [Abstract][Full Text] [Related]
59. Paclitaxel and carboplatin in head and neck cancer.
Dunphy F; Boyd J; Dunleavy T
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-25-S19-27. PubMed ID: 9427261
[TBL] [Abstract][Full Text] [Related]
60. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.
Merlano M; Rosso R; Sertoli MR; Bonelli L; Margarino G; Grimaldi A; Benasso M; Gardin G; Corvó R; Scarpati D
J Clin Oncol; 1988 Apr; 6(4):627-32. PubMed ID: 2451713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
